Raymond James Trust N.A. purchased a new position in shares of Davita Inc (NYSE:DVA) during the first quarter, Holdings Channel reports. The firm purchased 2,974 shares of the company’s stock, valued at approximately $202,000.

Other large investors also recently bought and sold shares of the company. SRS Capital Advisors Inc. bought a new stake in Davita during the fourth quarter worth about $118,000. Seven Bridges Advisors LLC raised its stake in Davita by 187.1% in the third quarter. Seven Bridges Advisors LLC now owns 3,066 shares of the company’s stock worth $203,000 after buying an additional 1,998 shares during the period. Acrospire Investment Management LLC raised its stake in Davita by 166.7% in the third quarter. Acrospire Investment Management LLC now owns 3,200 shares of the company’s stock worth $211,000 after buying an additional 2,000 shares during the period. Ironwood Investment Management LLC raised its stake in Davita by 26.7% in the third quarter. Ironwood Investment Management LLC now owns 3,796 shares of the company’s stock worth $251,000 after buying an additional 800 shares during the period. Finally, Smith Shellnut Wilson LLC ADV bought a new stake in Davita during the fourth quarter worth about $248,000. Institutional investors and hedge funds own 85.31% of the company’s stock.

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Davita Inc (NYSE:DVA) opened at 68.43 on Friday. Davita Inc has a 12-month low of $54.50 and a 12-month high of $78.77. The company has a 50-day moving average price of $67.93 and a 200-day moving average price of $64.57. The firm has a market capitalization of $13.32 billion, a PE ratio of 15.95 and a beta of 1.02.

Davita (NYSE:DVA) last posted its earnings results on Thursday, February 16th. The company reported $0.98 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.91 by $0.07. The business had revenue of $3.72 billion for the quarter, compared to analyst estimates of $3.74 billion. Davita had a net margin of 4.92% and a return on equity of 16.16%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.12 EPS. On average, analysts predict that Davita Inc will post $3.57 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This story was first reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of United States & international trademark & copyright laws. The original version of this story can be accessed at http://www.dailypolitical.com/2017/04/21/2974-shares-in-davita-inc-dva-acquired-by-raymond-james-trust-n-a.html.

A number of equities research analysts have recently issued reports on the company. Zacks Investment Research lowered Davita from a “buy” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada reiterated a “hold” rating and issued a $62.00 price objective on shares of Davita in a report on Friday, February 17th. Finally, TheStreet upgraded Davita from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $70.33.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

5 Day Chart for NYSE:DVA

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).

Receive News & Ratings for Davita Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita Inc and related companies with MarketBeat.com's FREE daily email newsletter.